Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
52 Cards in this Set
- Front
- Back
Class I Antiarrhythmics
|
block Na+
|
|
Class II Antiarrhythmics
|
Beta blockade
|
|
Class III Antiarrhythmics
|
block K+ channels
|
|
Class IV Antiarrhythmics
|
block Ca2+ channels
|
|
Class Ia Antiarrhythmics do what?
|
inhibit Na+ and K+ channels
slow conduction time increase refractoriness/prolonged repolarization decrease automaticity lengthen action potential useful for supraventricular and ventricular arrythmias |
|
Quinidine
|
Class IA antiarrhythmic
blocks Na+ channels, delayed K+ channels, alpha-adrenergic receptor blocker alkaloid of cinchona bark Adverse affects: anticholinergic, cinchonism (headache, dizzy, tinnitus), torsade de points (long QT) metabolism via Cyp 3A4 Decreases clearance of digoxin |
|
Procainamide
|
Class IA antiarrhythmic
blocks Na+ channels, delayed K+ channels Adverse effects: lupus-like syndrome w/antinuclear Ab, joint pain and rash; Torsade |
|
Disopyramide
|
Class Ia antiarrhythmic
blocks Na+ channels, delayed K+ channels Adverse effects: pronounced anticholinergic effects: dry mouth, constipation, urinary retention, precipitate glaucoma; Torsade |
|
Class Ib antiarrythmics do what?
|
Inhibit Na+ channels
decrease automaticity increase threshold for excitability slow conduction time no effect or shortened action potential frequency-dependent blockade = prefers activated and inactivated Na+ (not resting) => greater effect on ischemic and rapidly driven tissues (Purkinje and ventricular cells) |
|
Lidocaine
|
Class Ib antiarrhythmic
acute IV therapy rapidly blocks activated and inactivated (but not resting) Na+ channels so greater effect on ischemic and rapidly-driven tissues Good for ventricular arrythmias and fibrillation; NOT atrial arrythmias |
|
Mexilitine
|
Class IB antiarrhythmic
orally active lidocaine ventricular arrythmias; NOT atrial arrythmias |
|
Phenytoin
|
Class IB antiarrhythmic
second line antiarrythmic used as anticonvulsant in epilepsy (Dilantin) effective against digitalis-induced disrhythmias |
|
Class Ic antiarrythmics do what?
|
Strong inhibition of Na+ channels
markedly depresses slope of phase 0 in fast tissues slows conduction in fast tissues no effect on A.P. duration |
|
Flecainide
|
Class IC antiarrhythmic
blocks Na+ in all parts of heart decreases conduction speed used for sinus rhythm in supraventricular arrythmias in patients *without* structural heart disease adverse effects: rarely used due to increased mortality |
|
Propafenone
|
Class Ic antiarrhythmic
oral therapy for life-threatening ventricular arrythmias adverse effects: dizziness, taste disturbances, blurred vision |
|
Moricizine
|
Class IC antiarrhythmic
for ventricular arrythmias Adverse effects: don't use in those with MI due to increased mortality |
|
What ion is responsible for Phase 0 in a non-pacemaker cell?
|
Na+ channels open (depolarization)
|
|
What ion is responsible for Phase 1 in a non-pacemaker cell?
|
N+ channels close, K+ open (initial rapid repolarization)
|
|
What ion is responsible for Phase 2 in a non-pacemaker cell?
|
Decreased K+ conductance, Ca2+ movement into cell (plateau)
|
|
What ion is responsible for Phase 3 in a non-pacemaker cell?
|
Voltage-activated Ca2+ channels close, leaving K+ open (repolarization)
|
|
What ion is responsible for Phase 4 in a non-pacemaker cell?
|
None--resting state
|
|
What ion is responsible for Phase 0 in a pacemaker cell?
|
Ca2+ (depolarization)
|
|
What ion is responsible for Phase 3 in a pacemaker cell?
|
K+ (repolarization)
|
|
What ion is responsible for Phase 4 in a pacemaker cell?
|
Na+ (spontaneous depolarization)
|
|
Beta-adrenergic stimulation of the heart is from what part of the autonomic nervous system?
|
Sympathetic (Parasympathetic stimulates muscarinic)
|
|
Beta-adrenergic stimulation of the heart causes
|
Increased contractility
increased SA node automaticity accelerated AV node conduction accelerated HIS/Purkinje conduction |
|
Describe the process by which beta-adrenergic stimulation of the heart affects it in terms of ions, cellular products, and heart behavior
|
receptor stimulation => increased cAMP => opens Ca2+ channels => increased intracellular Ca2+ => increased contractility
and elevates phase 4 slope => increases SA node automaticity => increased heart rate |
|
What are Class II Beta-blocker effects on the action potential?
|
Decrease automaticity!
Decrease AV node conduction (prolonged repolarization at AV node) Prolong refractory period (decreased slope of phase 4 depolarization) Antiarrythmic mainly by reducing automaticity of ectopic pacemakers and by slowing conduction in slow fibers |
|
What is the only antiarrhythmic found to decrease sudden cardiac death in patients with prior MI?
|
Beta-adrenergic receptor blocker
|
|
What are the adverse effects of Beta-blockers?
|
fatigue
depression impotence hypotension AV block |
|
Propranolol
|
Class II antiarrhythmic: Beta-adrenergic receptor blocker
Useful for atrial and ventricular arrythmias; re-entrant arrythmias involving AV node; atrial flutter & fibrillation Side effects: fatigue, depression, impotence, hypotension, AV block |
|
Acebutolol
|
Class II antiarrhythmic: Beta-adrenergic receptor blocker
Useful for atrial and ventricular arrythmias; re-entrant arrythmias involving AV node; atrial flutter & fibrillation Side effects: fatigue, depression, impotence, hypotension, AV block |
|
Esmolol
|
Class II antiarrhythmic: Beta-adrenergic receptor blocker
IV only Useful for atrial and ventricular arrythmias especially after cardiac surgery; re-entrant arrythmias involving AV node; atrial flutter & fibrillation Side effects: fatigue, depression, impotence, hypotension, AV block |
|
How do Class III antiarrhythmics work?
|
Class III antiarrhythmics block repolarizing K+ channels (phase 2) and prolonged repolarization (phase 3), leading to prolonged action potential
|
|
Amiodarone
|
Class III antiarrhythmic: K+ channel blocker
Blocks K+, Na+, Ca2+ channels and alpha and beta-adrenergic receptors Used for: sustained ventricular tachycardia (IV), ventricular fibrillation (IV), and maintenance of normal sinus in atrial fib (oral) Adverse effects: asymptomatic AV block; pulmonary fibrosis (dose-related) so monitor chest x-ray and pulmonary function tests; corneal microdeposits (often asymptomatic); hepatic dysfunction; photosensitivity; thyroid dysfunction (hypo- or hyper-) PROFOUND drug interactions vi P450 3A4 and slow elimination (1/2 life 53 days) |
|
Sotalol
|
Class III antiarrhythmic: non-selective Beta blocker and K+ channel blocker
(like a beta blocker class II and class III K+ channel, therefore decreases automaticity and increases refractoriness like a beta; prolongs action potential and QT interval like a K+ channel blocker) Adverse effects: same as Beta blocker, torsade de pointes (from prolonged AP) Not metabolized, renally eliminated Used for life-threatening ventricular arrhythmias and maintenance of sinus rhythm in atrial fibrillation Class II antiarrhythmic: Beta-adrenergic receptor blocker (also blocks K+ channels) Useful for atrial and ventricular arrythmias; re-entrant arrythmias involving AV node; atrial flutter & fibrillation Side effects: fatigue, depression, impotence, hypotension, AV block |
|
Ibutilide
|
Class III antiarrhythmic: K+ channel blocker
Used via rapid infusion for conversion of atrial fibrillation or flutter to sinus Adverse effect: Torsade |
|
Dofetilide
|
Class III antiarrhythmic: K+ channel blocker
PURE K+ channel blocker: slows AP and increases refractory period in atria and ventricle Used for conversion of atrial fib/flutter to normal sinus rhythm & maintenance of normal sinus rhythm in atrial fibrillation Adverse effect: prolonged QT and torsade (dose-related) |
|
How do Class IV antiarrhythmics work?
|
Ca2+ channel blockers.
Decrease slope of phase 0 of action potential on both SA and AV nodes, and prolong AV node repolarization. Both actions delay conduction through AV node => prevent re-entry |
|
What are the two subclasses of Ca2+ channel blockers?
|
dihydropyridine (nifedipine)
nondihydropyridines (diltiazem and verapamil) |
|
Dihydropyridines are selective for what tissue type?
|
Dihydropyridines=nifedipine
selective for vascular tissue |
|
Nondihydropyridines are selective for what tissue type?
|
Nondihydropyridines = diltiazem and verapamil
selective for cardiac tissue |
|
Describe the Class III antiarrhythmic cardiac effects
|
decreased contractility
reduced SA node impulse generation, slowed AV node conduction verapamil > diltiazem > nifedipine |
|
Describe the Class IV antiarrythmic vascular effects
|
vasodilation
nifedipine > diltiazem > verapamil |
|
Tissue selectivity in Class III antiarrhythmics can result in opposite heart effects T or F? Explain.
|
True
nifedipine increases HR; verapamil slows HR. Nifedipine is most likely to cause reflex tach since it causes pronounced vasodilation without inhibiting SA/AV node conduction. Verapamil and diltiazem are not as likely since they have weaker vasodilation effects but they slow the heart by depressing SA and AV node function directly. |
|
Which calcium channel blocker increases heart rate?
|
nifedipine (the dihydropyridine)
|
|
Which calcium channel blocker slows SA/AV node conduction?
|
nondihydropyridines (verapamil and diltiazem)
|
|
Verapamil
|
Class IV: Ca2+ channel blocker
Nondihydropyridine: targets cardiac tissue Used for rate control: reduce ventricular rate in atrial fib/flutter. Adverse effects: constipation; inhibits P450 3A4, so possible drug interactions; increases serum digoxin concentrations |
|
Diltiazem
|
Class IV: Ca2+ channel blocker
Nondihydropyridine: targets cardiac tissue (in-between cardiac and vascular) Used for rate control: reduce ventricular rate in atrial fib/flutter. Adverse effects: constipation; inhibits P450 3A4, so possible drug interactions; increases serum digoxin concentrations |
|
Nifedipine
Amlodipine Felodipine |
Class IV: Ca2+ channel blocker
dihydropyridine: blocks Ca2+ in vascular smooth muscle NOT USEFUL IN TREATING ARRHYTHMIAS since cardiac effects are due to reflex sympathetic activation secondary to peripheral vasodilation. |
|
Adenosine
|
Nonclassified antiarrhythmic
activates K+ channels in AV and SA node, hyperpolarizes atrial tissues. Shortens refractory period. Acute termination of re-entrant drug of choice for superventricular arrythmias which are AV node dependent. IV only (t1/2 = 10 secs) Adverse effects: proarrythmic effects but only lasts a few seconds |
|
Digoxin
|
Cardiac Glycoside antiarrhythmic
Inhibits Na+/K+ ATPase => increased intracellular Na+ => inhibition of Na+/Ca2+ exchanger => increases intracellular Ca2+ => more Ca2+ released => more contraction = positive inotropic effect. Decreased SA node automaticity and slowed AV node conduction as a result of enhancing parasympathetic and decreasing sympathetic regulation of heart = negative chronotrope. Slows AV node conduction. Used for heart failure (increased contractility) and atrial fibrillation (slows rate and conduction). Do not use in patients with low EF. Adverse effects: narrow therapeutic window; can stimulate almost any type of arrythmia; GI effects from toxicity including nausea, vomiting, diarrhea, and anorexia = digoxin toxicity; visual disturbances (yellow-green vision); electrolyte disturbances (esp. K+). Drug interaction: amiodarone increases digoxin concentrations. Counteract with Digibind. |